Stirling Ultracold and Catalent establish cold chain partnership epmmagazine.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from epmmagazine.com Daily Mail and Mail on Sunday newspapers.
BioLife Solutions Announces Closing of Stirling Ultracold Acquisition and Expanded Partnership with Leading Global Biopharma CDMO
Stirling Named Preferred Provider of Ultra Low Temperature (ULT) Storage Across Multiple Business Units
Customer Uses BioLife s Entire Bioproduction Portfolio Including Biopreservation Media, Thaw Systems, Cold Chain Management, Cryogenic Freezers and Storage Services
News provided by
Share this article
, Inc.(NASDAQ: BLFS) ( BioLife or the Company ), a leading developer and supplier of a portfolio of class-defining bioproduction products and services for cell and gene therapies and the broader biopharma market, today announced that it has closed the previously announced acquisition of Stirling Ultracold ( Stirling ), a privately held manufacturer of ultra-low temperature ( ULT ) mechanical freezers. BioLife issued 6,646,870 shares of common stock in exchange for 100% of the outstanding shares of Stirling.
Catalent and Stirling Ultracold Announce Partnership to Establish Energy-Efficient Cold Chain Capabilities for Biologics and Emerging Modalities
Share Article
Catalent, the leading global provider of advanced delivery technologies, development, manufacturing, and clinical supply solutions for drugs, biologics, cell and gene therapies, and consumer health products, and Stirling Ultracold, the innovative developer and manufacturer of ultra-low temperature (ULT) freezers for life science and biopharma research, today announced a partnership whereby Stirling Ultracold becomes the preferred provider of ULT storage across Catalent’s multiple business units.
Catalent is focused on providing safe, reliable product supply, and has responded to the rapid growth in new therapeutic modalities such as cell and gene therapies with solutions and capacity to match the significant demand for these therapies
WHEN we think of the heroes of the current pandemic, frontline health workers and those who work on bringing effective vaccines to market come to mind. But a Scotsman of the cloth and self -taught engineer born in the late 18th century is unlikely to be viewed as a prime candidate. However, many experts believe the refrigeration technology of Robert Stirling, which he first patented in 1816, is making the vaccination programme possible. His work is, apparently, experiencing a renaissance. Systems based on his findings are being employed in laboratory and hospital settings where a cold chain is required in the development of a vaccine and, in the case of some, to the point where it goes into a patient’s arm.
11 WHITE SANDS MISSILE RANGE, N.M. (April 13, 2021) – In response to the coronavirus pandemic, McAfee U.S. Army Health Clinic at White Sands Missile Range launched an aggressive vaccination campaign and obtained an ultra-low freezer to store the vaccinations safely.
In 2020, the announcement went out that the Pfizer-BioNTech and Moderna’s COVID-19 vaccinations would soon be available with specific temperature storage requirements. After the announcement, Lt. Col. Aaron Braxton II, McAfee U.S. Army Health Clinic Commander, and his team knew that the vaccine s distribution and storage efforts would prove to be a challenge due to the distance and large size of the installation.